We are live on ! Find out more
BSA

Braun Stacey Associates Portfolio holdings

AUM $3.01B
1-Year Est. Return 47.79%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+47.79%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.01B
AUM Growth
-$77.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
119
New
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
+$28.4M
2
+$17.1M
3
+$14.5M
4
IQV icon
IQVIA
IQV
+$13.6M
5
R icon
Ryder
R
+$12M

Top Sells

Rank Stock Value
1
+$25.9M
2
+$22.6M
3
+$12.1M
4
MU icon
Micron Technology
MU
+$11.7M
5
WDC icon
Western Digital
WDC
+$9.36M

Sector Composition

Rank Sector Weight
1 Technology 30.15%
2 Financials 13.03%
3 Communication Services 10.89%
4 Industrials 10.55%
5 Healthcare 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$5.02T
$195M 6.48%
1,117,419
+1,784
AAPL icon
2
Apple
AAPL
$4.81T
$166M 5.51%
652,506
+205
MSFT icon
3
Microsoft
MSFT
$2.95T
$126M 4.2%
341,325
+1,609
AMZN icon
4
Amazon
AMZN
$2.66T
$93.3M 3.1%
448,052
-1,506
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.24T
$91.2M 3.03%
317,123
+4,793
AVGO icon
6
Broadcom
AVGO
$1.84T
$70.8M 2.35%
228,819
-8,001
LITE icon
7
Lumentum
LITE
$65.2B
$64.5M 2.15%
91,844
-16,912
XOM icon
8
ExxonMobil
XOM
$629B
$64.4M 2.14%
379,572
-2,504
META icon
9
Meta Platforms (Facebook)
META
$1.63T
$60.8M 2.02%
106,264
-3,505
VRT icon
10
Vertiv
VRT
$117B
$60.4M 2.01%
241,147
-16,399
WDC icon
11
Western Digital
WDC
$189B
$56.1M 1.87%
207,494
-35,872
JPM icon
12
JPMorgan Chase
JPM
$918B
$52.4M 1.74%
178,152
-4,087
MU icon
13
Micron Technology
MU
$1.1T
$48.3M 1.61%
143,092
-29,895
HWM icon
14
Howmet Aerospace
HWM
$112B
$47.5M 1.58%
206,271
-10,092
GOOG icon
15
Alphabet (Google) Class C
GOOG
$4.22T
$46.6M 1.55%
162,389
+247
WELL icon
16
Welltower
WELL
$173B
$43.9M 1.46%
222,073
-2,080
PWR icon
17
Quanta Services
PWR
$95.9B
$40.6M 1.35%
73,952
-2,987
TJX icon
18
TJX Companies
TJX
$172B
$38.5M 1.28%
241,227
-869
LLY icon
19
Eli Lilly
LLY
$1.05T
$38.2M 1.27%
41,570
-214
JNJ icon
20
Johnson & Johnson
JNJ
$599B
$37.4M 1.24%
153,148
+4,292
RTX icon
21
RTX Corp
RTX
$262B
$36.8M 1.22%
191,007
+13
ETR icon
22
Entergy
ETR
$52.2B
$35.3M 1.17%
313,845
-2,768
LRCX icon
23
Lam Research
LRCX
$403B
$34.4M 1.14%
160,780
-2,567
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.06T
$34.3M 1.14%
71,622
-1,167
TRV icon
25
Travelers Companies
TRV
$81.3B
$34M 1.13%
116,402
-762
1
2 3 4 5

Similar funds

CI
Conning Inc Hartford, Connecticut $3.01B AUM 16.23% 1-Year Est. Return
BGDI
BW Gestao de Investimentos Sao Paulo, Brazil $3.01B AUM 27.43% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3B AUM 24.41% 1-Year Est. Return
KIA
KCM Investment Advisors Greenbrae, California $3.01B AUM 21.97% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return

Braun Stacey Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Braun Stacey Associates held 119 positions worth $3.01B, down 2.5% from $3.09B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Braun Stacey Associates's Q1 2026 filing shows 6 new, 40 increased, 57 reduced and 7 closed positions. Its largest new stake was Merck: 246,022 shares worth $29.6M. The largest sale was Neurocrine Biosciences, an estimated $25.9M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Financials and Communication Services.

  • Braun Stacey Associates's largest Q1 2026 buy was Merck: 246,022 shares worth $29.6M.
  • Braun Stacey Associates added most to Ascendis Pharma A/S in Q1 2026, an estimated $2.67M increase.
  • Braun Stacey Associates's biggest Q1 2026 reduction was Boston Scientific, cutting an estimated $12.1M.
  • Braun Stacey Associates fully exited Neurocrine Biosciences in Q1 2026, selling an estimated $25.9M.
  • Braun Stacey Associates's ten largest holdings make up 33% of its $3.01B portfolio in Q1 2026.
  • Braun Stacey Associates opened 6 new positions and closed 7 in Q1 2026.
  • Braun Stacey Associates's portfolio value fell 2.5% quarter-over-quarter to $3.01B.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.